FDA Approved: NAPROXEN — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approves Aurobindo Pharma Limited's supplemental application for naproxen (generic) under ANDA075390. This action constitutes a supplemental approval for th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Bursitis
• Dysmenorrhea
• Gout
• Juvenile Idiopathic Arthritis
• Osteoarthritis
• Rheumatoid Arthritis
• Tendinitis

Drugs mentioned

• Naproxen (Naproxen)

Snippet

SUPPL AP for NAPROXEN (NAPROXEN)